Acalabrutinib–Venetoclax improves progression-free survival and reduces disease progression in untreated chronic lymphocytic ...

During a Case-Based Roundtable® event, Nitin Jain, MD, and participants discussed treating a patient with CLL after ...

Leukemia is a group of cancers that develop in blood cells. CLL develops in a type of white blood cell called lymphocytes. The rapid division of lymphocytes can crowd out healthy blood cells.

An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) ...

A new international study has found that a simple tablet treatment could improve survival rates for people with chronic ...

According to The Leukemia and Lymphoma Society, for 2% to 10% of patients with CLL, the disease will ... taken from a patient’s blood, are changed in a laboratory so that they will learn to attack ...

Leukemias and lymphomas are often grouped together because they are both blood-related cancers that originate in lymphocytes. However, leukemia originates in the bone marrow and spreads through the ...

The symptoms are largely due to the onset of anemia (characterized by the loss of red blood cells) and thrombocytopenia (the ... and they progress at a far slower rate. Chronic lymphocytic leukemia ...